What is the differential diagnosis of a leucemoid (leukocyte disorder) reaction in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Leukemoid Reaction

A leukemoid reaction is defined as reactive leukocytosis exceeding 40-50 × 10⁹/L with significant increase in early neutrophil precursors, and the differential diagnosis must systematically exclude chronic myelogenous leukemia (CML) and chronic neutrophilic leukemia (CNL) before identifying the underlying reactive cause. 1, 2

Primary Exclusions Required

Before diagnosing a leukemoid reaction, you must rule out:

  • Chronic myelogenous leukemia (CML) - This is the critical first step, as CML can present identically with marked leukocytosis and left shift 1
  • Chronic neutrophilic leukemia (CNL) - A rare myeloproliferative neoplasm that closely mimics leukemoid reaction and requires bone marrow evaluation and molecular testing to distinguish 1, 3
  • Acute myeloid leukemia (AML) - Particularly when hyperleukocytosis (WBC >100 × 10⁹/L) is present, as this represents a medical emergency requiring immediate cytoreduction 4, 5
  • Other myeloproliferative neoplasms - Including polycythemia vera, essential thrombocythemia, and primary myelofibrosis 4

Major Causes of True Leukemoid Reaction

Once malignancy is excluded, the differential includes:

Infectious Causes (Most Common)

  • Severe bacterial infections - The most frequent cause, involving multiple organisms including gram-positive and gram-negative bacteria 2, 6
  • Tuberculosis - Particularly in patients with travel exposure to endemic areas 7
  • Endocarditis - Should be considered with recurrent infections and monocytosis 7
  • Ehrlichiosis - Look for morulae in monocytes on peripheral smear 7
  • Parasitic infections - Consider with appropriate travel history 7

Malignancy-Related (Second Most Common)

  • Paraneoplastic syndrome from solid tumors - Particularly sarcomatoid renal cell carcinoma, poorly differentiated carcinomas, and other nonhematopoietic malignancies 2, 8, 3
  • This carries an extremely poor prognosis with high mortality 2, 8

Other Causes

  • Severe hemorrhage - Acute blood loss can trigger marked reactive leukocytosis 1
  • Acute hemolysis - Massive hemolytic episodes 1
  • Drug intoxications - Various medications and toxic exposures 1
  • Adult-onset Still's disease - Presents with fever spikes, sore throat, salmon-colored rash, and monocytosis in 51-87% of cases 7
  • Autoimmune disorders - Including systemic lupus erythematosus and rheumatoid arthritis 7

Diagnostic Algorithm

Step 1: Confirm the Count and Review Peripheral Smear

  • Calculate absolute counts - Don't rely solely on automated differentials 7
  • Manual differential is mandatory - Automated analyzers miss critical morphologic features 7, 6
  • Look for activated neutrophil changes - These suggest reactive process rather than malignancy 6
  • Identify dysplasia - Pseudo-Pelger-Huët anomaly, hypogranulation suggest myelodysplastic syndrome or CMML 7
  • Count blasts and blast equivalents precisely - >1% blasts or promonocytes raises concern for CMML 7

Step 2: Exclude Hematologic Malignancy

  • Bone marrow aspirate and biopsy - Required when absolute monocyte count ≥1 × 10⁹/L persists >3 months without identified reactive cause, or when concurrent cytopenias, dysplastic features, or constitutional symptoms are present 7
  • Cytogenetic analysis - Conventional karyotyping to exclude CML and other myeloid neoplasms 5, 7
  • Molecular testing - BCR-ABL for CML, JAK2 mutations for other myeloproliferative neoplasms 5
  • Flow cytometry - To characterize cell populations and exclude lymphoproliferative disorders 5, 6

Step 3: Identify Underlying Reactive Cause

  • Targeted infectious workup - Blood cultures, imaging for occult infections, tuberculosis testing, HIV, hepatitis C 7
  • Imaging for solid tumors - CT chest/abdomen/pelvis if paraneoplastic syndrome suspected 7
  • Inflammatory markers - ESR and CRP (virtually always elevated in Adult-onset Still's disease and CMML) 7
  • Autoimmune serologies - If constitutional symptoms or physical findings suggest autoimmune disease 7

Critical Pitfalls to Avoid

  • Don't confuse relative and absolute monocytosis - Always calculate absolute monocyte count from total WBC and differential percentage 7
  • Don't attribute persistent monocytosis to inflammation without excluding infection - Tuberculosis, endocarditis, and parasitic infections require specific treatment 7
  • Don't delay bone marrow evaluation beyond 3 months in unexplained monocytosis - CMML has poor prognosis and early identification allows consideration of allogeneic stem cell transplantation 7
  • Don't miss hyperleukocytosis (WBC >100 × 10⁹/L) as a medical emergency - This requires immediate cytoreduction with hydroxyurea 50-60 mg/kg/day and measures to prevent tumor lysis syndrome 4, 5
  • Don't give excessive red blood cell transfusions in hyperleukocytosis - This increases blood viscosity and worsens symptoms 5

Prognostic Implications

Leukemoid reaction carries a poor prognosis regardless of etiology, with high mortality rates. 2 Lower hemoglobin, older age, and increased segmented neutrophil count are associated with increased risk of death 2. Paraneoplastic leukemoid reaction is particularly ominous and may serve as a predictor of poor prognosis in patients with solid tumors 8, 3.

References

Research

Leukemoid reaction: A 21st-century cohort study.

International journal of laboratory hematology, 2020

Guideline

Diagnostic Approach and Management of Leukocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Acute Myeloid Leukemia (AML) in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Malignant or benign leukocytosis.

Hematology. American Society of Hematology. Education Program, 2012

Guideline

Management of Neutrophilia with Normal Leukocyte Count and Monocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.